Available datapackage for study 'Randomized, OpenLabel, Phase 3 Trial of Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Early Stage NSCLC'
收藏DataCite Commons2026-04-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00012121.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this neoadjuvant study is to compare nivolumab plus chemotherapy and chemotherapy alone in terms of safety and effectiveness, and to describe nivolumab plus ipilimumab's safety and effectiveness in treating resectable NSCLC.This study has multiple primary endpoints.
提供机构：
Vivli
创建时间：
2026-04-05
